Published in N Engl J Med on October 26, 2017
Abiraterone in Metastatic Prostate Cancer. N Engl J Med (2017) 0.75
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. N Engl J Med (2017) 4.48
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res (2009) 3.57
PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations. Cancer Res (2008) 1.52
Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma. Lab Invest (2007) 1.10
XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC. IDrugs (2010) 1.09
Primary lymphoma of the ovary. J Cancer Res Ther (2008) 1.06
Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status. J Cancer Res Ther (2009) 1.01
Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy. Mol Cancer Ther (2009) 0.99
Advanced adenoid cystic carcinoma of the cervix: a case report and review of the literature. Cases J (2009) 0.98
Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience. BMC Urol (2009) 0.97
Primary nasopharyngeal Hodgkin's disease: case report and literature review. J Med Case Rep (2010) 0.95
A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival. Neuro Oncol (2013) 0.87
Breast cancer treatment and sexual dysfunction: Moroccan women's perception. BMC Womens Health (2011) 0.87
Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition. Clin Cancer Res (2013) 0.86
Choroidal metastasis from tubulopapillary renal cell carcinoma: a case report. Cases J (2009) 0.86
A Synchronous undifferentiated nasopharyngeal carcinoma and infiltrating ductal carcinoma of the breast successfully treated with induction chemotherapy followed by local control of both tumours: a case report. BMC Ear Nose Throat Disord (2011) 0.86
A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy. Neoplasia (2013) 0.85
Primary lymphoma of the prostate treated with rituximab-based chemotherapy: a case report and review of the literature. Cases J (2009) 0.83
Treatment trends and outcomes of small-cell carcinoma of the bladder: in regard to Koay et al. (Int J Radiat Oncol Biol Phys 2011 Oct 20). Int J Radiat Oncol Biol Phys (2012) 0.80
In regard to Rehman et al. Re: Modern outcomes of inflammatory breast cancer. Int J Radiat Oncol Biol Phys (2013) 0.80
Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients. Eur Arch Otorhinolaryngol (2009) 0.80
Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer. BMC Res Notes (2010) 0.79
[Chemotherapy in gallbladder carcinoma]. Presse Med (2010) 0.79
An unusual presentation of non-Hodgkin lymphoma: cardiac involvement. J Cancer Res Ther (2010) 0.79
Breast cancer in moroccan young women: a retrospective study. BMC Res Notes (2010) 0.79
Triple malignancy in a single patient including a cervical carcinoma, a basal cell carcinoma of the skin and a neuroendocrine carcinoma from an unknown primary site: A case report and review of the literature. J Med Case Rep (2011) 0.78
Management of stage one and two-E gastric large B-cell lymphoma: chemotherapy alone or surgery followed by chemotherapy? J Hematol Oncol (2010) 0.78
Management of anorectal melanoma: report of 17 cases and literature review. J Gastrointest Cancer (2012) 0.78
The Practice of Medical Oncology in Morocco: The National Study of the Moroccan Group of Trialist in Medical Oncology (EVA-Onco). ISRN Oncol (2013) 0.77
Symptomatic hypopituitarism revealing primary suprasellar lymphoma. BMC Endocr Disord (2010) 0.77
A rare case of nephrotic syndrome revealing mycosis fungoide managed successfully with chemotherapy. Pan Afr Med J (2012) 0.75
Primary Nasopharyngeal non-Hodgkin lymphomas: a retrospective review of 26 Moroccan patients. BMC Ear Nose Throat Disord (2009) 0.75
Neoadjuvant chemotherapy in well-differentiated fetal adenocarcinoma: a case report. BMC Res Notes (2014) 0.75
Bevacizumab 5 or 7.5 mg/kg in metastatic colorectal cancer can be infused safely over 10 minutes. J Gastrointest Cancer (2012) 0.75
Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix. Int J Gynecol Cancer (2011) 0.75
Transitional cell carcinomas in the bladder and ovary: unusual primary association or metastatic lesions? Taiwan J Obstet Gynecol (2010) 0.75